BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
相关临床试验
90
83 进行中
药物批准
4
批准总数
监管机构
2
监管机构数
成立时间
N/A
进行中（未招募）
82
91.1%
已完成
1
1.1%
尚未招募
1
1.1%
招募中
5
5.6%
撤回
1
1.1%
暂无资讯文章
